In Vivo and in Silico Based Evaluation of Antidiabetic Potential of an Isolated Flavonoid from Allium hookeri in Type 2 Diabetic Rat Model.

Allium hookeri antidiabetic diabetes mellitus flavonoid molecular docking

Journal

Chemistry & biodiversity
ISSN: 1612-1880
Titre abrégé: Chem Biodivers
Pays: Switzerland
ID NLM: 101197449

Informations de publication

Date de publication:
04 Dec 2023
Historique:
received: 26 08 2023
accepted: 19 11 2023
medline: 4 12 2023
pubmed: 4 12 2023
entrez: 4 12 2023
Statut: aheadofprint

Résumé

Allium hookeri (F: Liliaceae), an indigenous plant of Manipur, India, is traditionally used to treat various diseases and disorders like diabetes, hypertension, and stomach ache. In our previous study, the methanol extract of the plant showed significant antidiabetic potential in rats. In the present study, we evaluated the antidiabetic potential of a flavonoid compound named MEA isolated from the methanolic leaf extract of A. Hookeri in rats. Additionally, we assessed the compound's mode of action through the molecular docking study. The MEA reduced the blood glucose level from 317±12.8 to 99.4±6.67 mg/dl after 21 days of treatment. Besides, MEA also restored the body weights and other biochemical parameters including lipid profile significantly compared to the diabetic group (p<0.001). The histoarchitecture of the pancreatic tissues of the MEA treated group was also improved compared to the diabetic group. In the docking study, the compound showed good binding affinity in the active binding site of the two structures of pancreatic beta-cell SUR1 (Sulfonylurea Receptor 1) subunit with CDocker energy -31.556 kcal/mol and -39.703 kcal/mol, respectively. The compound MEA was found to be drug-like with non-carcinogenic, non-mutagenic and non-irritant properties. These findings indicate the antidiabetic potential of MEA, which might act by modulating the pancreatic beta-cell SUR1 subunit present in the K

Identifiants

pubmed: 38047518
doi: 10.1002/cbdv.202301299
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e202301299

Subventions

Organisme : Department of Pharmaceutical Sciences, Dibrugarh University

Informations de copyright

© 2023 Wiley-VHCA AG, Zurich, Switzerland.

Références

W. H. Gispen, G. J. Biessels, Trends Neurosci. 2000, 23, 542-549.
I. Hameed, S. R. Masoodi, S. A. Mir, M. Nabi, K. Ghazanfar, B. A. Ganai, World J. Diabetes 2015, 6, 598-612.
P. Saeedi, I. Petersohn, P. Salpea, B. Malanda, S. Karuranga, N. Unwil, S. Colagiuri, L. Guariguata, A. A. Motala, K. Ogurtsova, J. E. Shaw, Diabetes Res. Clin. Pract. 2019, 157, 107843.
A. C. Powers, D. D'Alessio, Endocrine Pancreas and Pharmacotherapy of Diabetes Mellitus and Hypoglycemia, MacGraw-Hill, New York, 2011, p.632.
L. Luzi, New Engl. J. Med. 1998, 339, 115-117.
H. A. Spiller, T. S. Sawyer, Am. J. Health-Syst. Pharm. 2006, 63, 929-938.
C. Egbuna, C. G. Awuchi, G. Kushwaha, M. Rudrapal, K. C. Patrick-Iwuanyanwu, O. Singh, U. E. Odoh, J. Khan, J. Jeevanandam, S. Kumarasamy, V. O. Chukwube, Curr. Top. Med. Chem. 2021, 21, 1067-95.
L. D. Devi, ‘Folk Medicines of Ethnobiological Importance in Manipur’, 1990, Dhanapati, Imphal.
H. Lalramnghinglova, ‘Ethnomedicinal plants of Mizoram. Bishen Singh’, 2003, Mahendra Pal Singh Publisher, New Delhi.
S. S. Roh, O. J. Kwon, J. H. Yang, Y. S. Kim, S. H. Lee, J. S. Jin, Y. D. Jeon, T. Yokozawa, H. J. Kim, BMC Complementary Altern. Med. 2016, 16, 63.
K. D. Singh, D. Chetia, S. Mazumdar, Indo Am. J. Pharm. Res. 2013, 3, 4098-4104.
K. D. Singh, D. Chetia, B. Dey, Int. J. Pharm. Pharm. Sci. 2018, 10, 24-30.
S. D. Ramashankar, B. K. Sharma, Indian J. Hist. Sci. 2015, 50, 324-332.
R. K. Al-Ishaq, M. Abotaleb, P. Kubatka, K. Kajo, D. Büsselberg, Biomol. Eng. 2019, 9, 430.
D. C. Damasceno, A. O. Netto, I. L. Iessi, F. Q. Gallego, S. B. Corvino, B. Dallaqua, Y. K. Sinzato, A. Bueno, I. D. Calderon, M. V. Rudge, BioMed Res. Int. 2014, 2014, 1-11.
S. Goldstein, W. J. Reddy, Arch. Biochem. Biophys. 1970, 140, 181-189.
C. G. Proud, Biochem. Soc. Trans. 2006, 34, 213-216.
O. Ohaeri, Biosci. Rep. 2001, 21, 19-24.
R. Ananthan, M. Latha, K. M. Ramkumar, L. Pari, C. Baskar, V. N. Bai, Exp. Diabetes Res. 2003, 4, 183-189.
M. Taher, T. M. F. S. Tg Zakaria, D. Susanti, Z. A. Zakaria, BMC Complementary Altern. Med. 2016, 16, 1-2.
S. Ahmed, A. Rakib, M. A. Islam, B. H. Khanam, F. B. Faiz, A. Paul, M. N. Chy, N. M. Bhuiya, M. M. Uddin, S. M. Ullah, M. A. Rahman, Clin. Phytosci. 2019, 5, 1-3.
S. Mazumdar, T. Marar, J. Patki, S. Devarajan, V. Zambare, D. Swami, Clin. Phytosci. 2020, 6, 1-11.
D. Sola, L. Rossi, G. P. C. Schianca, P. Maffioli, M. Bigliocca, R. Mella, F. Corlianò, G. P. Fra, E. Bartoli, G. Derosa, Arch. Med. Sci. 2015, 11, 840-848.
B. B. Petrovska Pharmacogn. Rev. 2012, 6, 1-5.
OECD, ‘Test No. 423: Acute Oral Toxicity - Acute Toxic Class Method’ 2002, doi: 10.1787/9789264071001-en.
J. A. Junejo, M. Rudrapal, L. M. Nainwal, K. Zaman, Biomed. Pharmacother. 2017, 95, 84-94.
J. A. Junejo, P. Mondal, V. K. Verma, M. Rudrapal, M. K. Zaman, Biomed. Pharmacol. J. 2014, 7, 635.
J. A. Junejo, G. Gogoi, J. Islam, M. Rudrapal, P. Mondal, H. Hazarika, K. Zaman, Future J. Pharm. Sci. 2018, 4, 93-101.
J. A. Junejo, K. Zaman, M. Rudrapal, N. Hussain, Biosci. Biotech. Res. Comm. 2020, 13, 860-7.
J. A. Junejo, K. Zaman, M. Ali, M. Rudrapal, Brazilian J. Pharm. Sci. 2021, 56.
N. Hussain, B. B. Kakoti, M. Rudrapal, Z. Rahman, M. Rahman, D. Chutia, K. K. Sarwa, Biosci. Biotech. Res. Comm. 2020, 13, 2211-2216.
J. A. Junejo, M. Rudrapal, K. Zaman, Indian J. Nat. Prod. Resour. 2020, 11, 18-29.
N. Gogoi, B. Bhuyan, Int. J. Pharm. Pharm. Sci. 2017, 9, 48-53.
D. A. Rees, J. C. Alcolado, Diabete Metab. 2005, 22, 359-370.
B. Bhuyan, D. Chetia, Indian J. Clin. Biochem. 2020, 35, 225-231.
J. X. Wu, D. Ding, M. Wang, Y. Kang, X. Zeng, L. Chen, Protein Cell. 2018, 9, 553-567.
G. M. Martin, M. W. Sung, Z. Yang, L. M. Innes, B. Kandasamy, L. L. David, C. Yoshioka, S. L. Shyng, eLife 2019, 8, e46417.
H. M. Berman, J. D. Westbrook, Z. Feng, L. Iype, B. Schneider, C. Zardecki, Acta Crystallogr. Sect. D: Biol. Crystallogr. 2002, D58, 889-898.
J. Bryan, A. Crane, W. Vila-Carriles, A. Babenko, L. Aguilar-Bryan, Curr. Pharm. Des. 2005, 11, 2699-2716.
N. Gogoi, D. Chetia, B. Gogoi, A. Das, Curr. Comput.-Aided Drug Des. 2021, 17, 69-82.
G. Wu, D. H. Robertson, C. L. Brooks, M. Vieth, J. Comput. Chem. 2003, 24, 1549-1562.
C. H. Lin, T. T. Chang, M. F. Sun, H. Y. Chen, F. J. Tsai, K. L. Chang, M. Fisher, C. Y. Chen, J. Biomol. Struct. Dyn. 2011, 28, 471-482.
C. Y. Lai, T. T. Chang, M. F. Sun, H. Y. Chen, F. J. Tsai, J. G. Lin, C. Y. Chen, Mol. Simul. 2021, 37, 250-256.
P. Ponnan, S. Gupta, M. Chopra, R. Tandon, A. S. Baghel, G. Gupta, A. K. Prasad, R. C. Rastogi, M. Bose, H. G. Raj, ISRN Struct. Biol. 2013, 2013.
A. K. Goswami, N. Gogoi, B. J. Gogoi, H. K. Sharma, Curr. Drug Ther. 2020, 15, 226-237.
J. A. Junejo, K. Zaman, R. Rudrapal, I. Celik, E. I. Attah, South African J. Bot. 2021, 143, 164-175.
N. Hussain, B. B. Kakoti, M. Rudrapal, K. K. Sarwa, I. Celik, E. I. Attah, S. J. Khairnar, S. Bhattacharya, R. K. Sahoo, S. G. Walode, Molbank 2021, 2021, M1234.

Auteurs

Khumanthem Deepak Singh (KD)

Escent Institute of Pharmaceutical Sciences and Research, Imphal, 795140, Manipur, India.

Dipak Chetia (D)

Department of Pharmaceutical Sciences, Faculty of Science and Engineering, Dibrugarh University, Dibrugarh, 786004, Assam, India.

Neelutpal Gogoi (N)

Department of Pharmaceutical Sciences, Faculty of Science and Engineering, Dibrugarh University, Dibrugarh, 786004, Assam, India.

Bhaskarjyoti Gogoi (B)

Department of Biotechnology, Royal School of Bio-Sciences, Royal Global University, Guwahati, 781035, India.

Mithun Rudrapal (M)

Department of Pharmaceutical Sciences, School of Biotechnology and Pharmaceutical Sciences, Vignan's Foundation for Science, Technology & Research (Deemed to be University), Guntur, 522213, Andhra Pradesh, India.

Classifications MeSH